OBJECTIVE: To describe invasive Haemophilus influenzae type b (Hib) infections in individuals aged 15 years or older in England and Wales between 1991 and 2003. DESIGN: Prospective, laboratory based surveillance of invasive Hib infections and cross sectional seroprevalence study. SETTING: England and Wales. PARTICIPANTS: Cases were confirmed by isolation of H influenzae from a normally sterile site, or from a non-sterile site in cases with a diagnosis of epiglottitis. Excess serum samples collected from English 30-39 year olds as part of a national serosurvey were identified for the years 1990, 1994, 1997, 2000, and 2002. MAIN OUTCOME MEASURES: The number of invasive Hib infections from 1991 to 2003. Population immunity to H influenzae type b in English adults was also measured. RESULTS: After routine infant immunisation was introduced in October 1992, adult Hib infections decreased initially but then rose from a low in 1998 to reach prevaccine levels in 2003. An associated fall in median Hib antibody concentrations occurred, from 1.29 microg/ml (95% confidence interval 0.90 to 1.64) in 1991 to 0.70 microg/ml (0.57 to 0.89) in 1994 (P = 0.006), with no significant change observed thereafter. CONCLUSIONS: Although immunisation of infants resulted in an initial decline in Hib infections in adults, a resurgence in reported cases occurred in 2002-3. This rise was associated with an increase in cases in children and evidence of reduced immunity in older unimmunised cohorts. Childhood immunisation programmes may have unanticipated effects on the epidemiology of disease in older age groups, and surveillance strategies must be targeted at entire populations.
OBJECTIVE: To describe invasive Haemophilus influenzae type b (Hib) infections in individuals aged 15 years or older in England and Wales between 1991 and 2003. DESIGN: Prospective, laboratory based surveillance of invasive Hib infections and cross sectional seroprevalence study. SETTING: England and Wales. PARTICIPANTS: Cases were confirmed by isolation of H influenzae from a normally sterile site, or from a non-sterile site in cases with a diagnosis of epiglottitis. Excess serum samples collected from English 30-39 year olds as part of a national serosurvey were identified for the years 1990, 1994, 1997, 2000, and 2002. MAIN OUTCOME MEASURES: The number of invasive Hib infections from 1991 to 2003. Population immunity to H influenzae type b in English adults was also measured. RESULTS: After routine infant immunisation was introduced in October 1992, adult Hib infections decreased initially but then rose from a low in 1998 to reach prevaccine levels in 2003. An associated fall in median Hib antibody concentrations occurred, from 1.29 microg/ml (95% confidence interval 0.90 to 1.64) in 1991 to 0.70 microg/ml (0.57 to 0.89) in 1994 (P = 0.006), with no significant change observed thereafter. CONCLUSIONS: Although immunisation of infants resulted in an initial decline in Hib infections in adults, a resurgence in reported cases occurred in 2002-3. This rise was associated with an increase in cases in children and evidence of reduced immunity in older unimmunised cohorts. Childhood immunisation programmes may have unanticipated effects on the epidemiology of disease in older age groups, and surveillance strategies must be targeted at entire populations.
Authors: Ger T Rijkers; Patricia E Vermeer-de Bondt; Lodewijk Spanjaard; Mijke A Breukels; Elisabeth A M Sanders Journal: Lancet Date: 2003-05-03 Impact factor: 79.321
Authors: Cynthia G Whitney; Monica M Farley; James Hadler; Lee H Harrison; Nancy M Bennett; Ruth Lynfield; Arthur Reingold; Paul R Cieslak; Tamara Pilishvili; Delois Jackson; Richard R Facklam; James H Jorgensen; Anne Schuchat Journal: N Engl J Med Date: 2003-05-01 Impact factor: 91.245
Authors: A B Gjini; J M Stuart; D A Lawlor; K A V Cartwright; H Christensen; M Ramsay; R S Heyderman Journal: Epidemiol Infect Date: 2006-06 Impact factor: 2.451
Authors: Caroline L Trotter; Ray Borrow; Jamie Findlow; Ann Holland; Sarah Frankland; Nick J Andrews; Elizabeth Miller Journal: Clin Vaccine Immunol Date: 2008-09-30
Authors: Claudio T Sacchi; Dietmar Alber; Peter Dull; Elizabeth A Mothershed; Anne M Whitney; Gwen A Barnett; Tanja Popovic; Leonard W Mayer Journal: J Clin Microbiol Date: 2005-08 Impact factor: 5.948
Authors: Leo M Schouls; Arie van der Ende; Ingrid van de Pol; Corrie Schot; Lodewijk Spanjaard; Paul Vauterin; Dorus Wilderbeek; Sandra Witteveen Journal: J Clin Microbiol Date: 2005-06 Impact factor: 5.948
Authors: Alessia Melegaro; Yoon Hong Choi; Robert George; W John Edmunds; Elizabeth Miller; Nigel J Gay Journal: BMC Infect Dis Date: 2010-04-08 Impact factor: 3.090
Authors: Jo Southern; Jodie McVernon; David Gelb; Nick Andrews; Rhonwen Morris; Annette Crowley-Luke; David Goldblatt; Elizabeth Miller Journal: Clin Vaccine Immunol Date: 2007-08-15